Company: AZN
Filing Date: 2025-07-29
Form Type: 6-K
Source: 0001104659-25-071432
Chunk: 11

Company: ASTRAZENECA PLC
Filing Date: 2025-07-29
Form: 6-K
Chunk 11
---
. It also presented 2024 Sustainability Highlights to investors and analysts |

| – | AstraZeneca was named in the top 20 of TIME’s Most Sustainable Companies, its highest ranking to date in the list of 500 businesses. AstraZeneca and Alexion were also included in Newsweek’s World’s Greenest Companies 2025 |

| – | AstraZeneca achieved the top ranking in IDEA Pharma’s index for 2025, coming first for “Invention” and joint third for “Innovation”. This annual ranking assesses companies’ ability to develop and commercialise products. |

| – | AstraZeneca has been A-rated for Supplier Engagement by CDP for 2024 and is on the Leaderboard for the third consecutive year, recognising its extensive supply chain engagement and focus on disclosing carbon emissions data and actions to CDP |

| – | The Company also ranked fourth in the 2025 Gartner Top 25 Supply Chains, the highest ranking for a pharmaceutical company this year |

| – | AstraZeneca SVP, Chief Digital Officer and CIO Cindy Hoots was ranked in the top 20 of this year’s Top 100 Women in Technology recognising her leadership in driving a digital-first strategy |

Sustainability impact Climate and nature

| – | Reducing the carbon impact of pressurised metered dose inhalers is a key product-related element of AstraZeneca’s Ambition Zero Carbon strategy. With an innovative next-generation propellant with 99.9% lower Global Warming Potential than current propellants, Breztri/Trixeo Aerosphere has received positive CHMP opinion and AstraZeneca will now begin to transition its Trixeo supply to the next-generation propellant in Europe |

| – | At London Climate Action Week, AstraZeneca joined His Majesty King Charles III, ministers from the UK and Brazil, and global leaders for an event on ‘Nature Action: Mobilising Frameworks and Finance’ and was also represented at several panel and roundtable discussions. The Company celebrated the use of 100% renewable energy for both heat and power at its Macclesfield site |

| – | The company participated in engagements with French, Italian and UK stakeholders, including a Circular Bioeconomy Alliance event in Rome in the presence of His Majesty King Charles III, as well as an event hosted by the French government on health systems decarbonisation. AstraZeneca showcased its pioneering work in quantifying the